Literature DB >> 11918690

Immunoglobulin A-deficient mice exhibit altered T helper 1-type immune responses but retain mucosal immunity to influenza virus.

Yongxin Zhang1, Susan Pacheco, Catherine L Acuna, Kirsten C Switzer, Ying Wang, Xyanthine Gilmore, Gregory R Harriman, Innocent N Mbawuike.   

Abstract

We have previously demonstrated that immunoglobulin A (IgA)(-/-) knockout (KO) mice exhibit levels of susceptibility to influenza virus infection that are similar to those of their normal IgA(+/+) littermates. To understand the mechanism of this apparent mucosal immunity without IgA, immunoglobulin isotype and T helper 1 (Th1)-type [interferon-gamma (IFN-gamma)] and Th2-type [interleukin (IL)-4, IL-5)] cytokine responses to influenza vaccine were evaluated. Intranasal immunization with influenza virus subunit vaccine plus cholera toxin/cholera toxin B subunit (CT/CTB) induced significant influenza virus-specific immunoglobulin G (IgG) antibody in the serum and nasal passages of both IgA(-/-) and IgA(+/+) mice, while IgA antibodies were induced only in IgA(+/+) mice. IgA KO mice exhibited an IgG1 subclass haemagglutinin (HA)-specific response but no detectable IgG2a and IgG2b responses. In contrast, IgA(+/+) mice exhibited significant IgG1 as well as IgG2a responses. This indicates a predominant Th2-type response in IgA KO mice compared to normal mice. Following stimulation with influenza virus in vitro, splenic lymphocytes from immunized IgA(-/-) mice produced significantly lower levels of IFN-gamma than IgA(+/+) mice (P < 0.001), but elaborated similar levels of IL-4 and IL-5. This was true at both protein and mRNA levels. Immunized mice were challenged intranasally with a small inoculum of influenza virus to allow deposition of virus in the nasal mucosal passages. Compared to non-immunized mice, immunized IgA(-/-) and IgA(+/+) mice exhibited significant, but similar levels of reduction in virus titres in the nose and lung. These results demonstrate that in addition to IgA deficiency, IgA gene deletion also resulted in down-regulated Th1-type immune responses and confirm our previous data that IgA antibody is not indispensable for the prevention of influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11918690      PMCID: PMC1782659          DOI: 10.1046/j.0019-2805.2001.01368.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  45 in total

Review 1.  The mucosal immune system: from fundamental concepts to vaccine development.

Authors:  J R McGhee; J Mestecky; M T Dertzbaugh; J H Eldridge; M Hirasawa; H Kiyono
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Target frequency and integration pattern for insertion and replacement vectors in embryonic stem cells.

Authors:  P Hasty; J Rivera-Pérez; C Chang; A Bradley
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

Review 3.  Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases.

Authors:  M Kilian; J Mestecky; M W Russell
Journal:  Microbiol Rev       Date:  1988-06

Review 4.  The heterogeneity of IgA deficiency.

Authors:  L A Hanson; J Björkander; B Carlsson; D Roberton; T Söderström
Journal:  J Clin Immunol       Date:  1988-05       Impact factor: 8.317

5.  The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain.

Authors:  A P McMahon; A Bradley
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

6.  Passive transfer of local immunity to influenza virus infection by IgA antibody.

Authors:  K B Renegar; P A Small
Journal:  J Immunol       Date:  1991-03-15       Impact factor: 5.422

7.  Immunoglobulin A mediation of murine nasal anti-influenza virus immunity.

Authors:  K B Renegar; P A Small
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

8.  New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection.

Authors:  L Winner; J Mack; R Weltzin; J J Mekalanos; J P Kraehenbuhl; M R Neutra
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

Review 9.  IgG subclass deficiency with or without IgA deficiency.

Authors:  L A Hanson; R Söderström; D E Nilssen; K Theman; J Björkander; T Söderström; G Karlsson; P Brandtzaeg
Journal:  Clin Immunol Immunopathol       Date:  1991-11

10.  Immunoglobulin levels in saliva in individuals with selective IgA deficiency: compensatory IgM secretion and its correlation with HLA and susceptibility to infections.

Authors:  G Norhagen; P E Engström; L Hammarström; P O Söder; C I Smith
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

View more
  22 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 2.  The role of secretory antibodies in infection immunity.

Authors:  Richard A Strugnell; Odilia L C Wijburg
Journal:  Nat Rev Microbiol       Date:  2010-08-09       Impact factor: 60.633

3.  The protective effect of antibody in immunity to murine chlamydial genital tract reinfection is independent of immunoglobulin A.

Authors:  Sandra G Morrison; Richard P Morrison
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging.

Authors:  Hideki Asanuma; Normaiza Binti Zamri; Shinichi Sekine; Yoshiko Fukuyama; Daisuke Tokuhara; Rebekah S Gilbert; Tatsuya Fukuiwa; Keiko Fujihashi; Tetsutaro Sata; Masato Tashiro; Kohtaro Fujihashi
Journal:  Vaccine       Date:  2011-11-17       Impact factor: 3.641

5.  Increased susceptibility of IgA-deficient mice to pulmonary Francisella tularensis live vaccine strain infection.

Authors:  Yoichi Furuya; Girish S Kirimanjeswara; Sean Roberts; Dennis W Metzger
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

6.  Induction of immune responses in mice after oral immunization with recombinant Lactobacillus casei strains expressing enterotoxigenic Escherichia coli F41 fimbrial protein.

Authors:  Jian-Kui Liu; Xi-Lin Hou; Chun-Hua Wei; Li-Yun Yu; Xiao-Jie He; Gui-Hua Wang; Jong-Soo Lee; Chul-Joong Kim
Journal:  Appl Environ Microbiol       Date:  2009-05-15       Impact factor: 4.792

Review 7.  Mouse models for the study of mucosal vaccination against otitis media.

Authors:  Albert Sabirov; Dennis W Metzger
Journal:  Vaccine       Date:  2008-02-04       Impact factor: 3.641

8.  Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency.

Authors:  I R Korponay-Szabó; I Dahlbom; K Laurila; S Koskinen; N Woolley; J Partanen; J B Kovács; M Mäki; T Hansson
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

9.  Differential requirements for protection against mucosal challenge with Francisella tularensis in the presence versus absence of cholera toxin B and inactivated F. tularensis.

Authors:  Constantine Bitsaktsis; Deepak B Rawool; Ying Li; Nitin V Kurkure; Bibiana Iglesias; Edmund J Gosselin
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

10.  Bordetella pertussis infection or vaccination substantially protects mice against B. bronchiseptica infection.

Authors:  Elizabeth M Goebel; Xuqing Zhang; Eric T Harvill
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.